{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:03Z","timestamp":1781513703810,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.surg.2025.109913","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:51:02Z","timestamp":1764593462000},"page":"109913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count"],"prefix":"10.1016","volume":"191","author":[{"given":"Jun","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Akabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odysseas P.","family":"Chatzipanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantis I.","family":"Tsilimigras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayed","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtaba","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Altaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Aucejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Chumbinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109913_bib1","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1245\/s10434-021-09871-6","article-title":"The landmark series: hilar cholangiocarcinoma","volume":"28","author":"Soares","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/cancers16010030","article-title":"Multi-disciplinary care of hilar cholangiocarcinoma: Review of guidelines and recent advancements","volume":"16","author":"Padmanaban","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109913_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrad024","article-title":"Surgical treatment of hilar cholangiocarcinoma: retrospective analysis","volume":"7","author":"Li","year":"2023","journal-title":"BJS Open"},{"key":"10.1016\/j.surg.2025.109913_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/cancers14092208","article-title":"Current perspectives on the surgical management of perihilar cholangiocarcinoma","volume":"14","author":"Hewitt","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109913_bib5","first-page":"18","article-title":"Hilar cholangiocarcinoma: diagnosis, treatment options, and management","volume":"3","author":"Soares","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.surg.2025.109913_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11605-022-05558-9","article-title":"Does adjuvant therapy benefit low-risk resectable cholangiocarcinoma? An evaluation of the NCCN guidelines","volume":"27","author":"Munir","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109913_bib7","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2025.109913_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2025.109913_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jso.24836","article-title":"Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: a multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium","volume":"117","author":"Krasnick","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hpb.2022.10.011","article-title":"Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy","volume":"25","author":"Endo","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109913_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14737140.2018.1473039","article-title":"Surgical approaches for the treatment of perihilar cholangiocarcinoma","volume":"18","author":"Kimbrough","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.surg.2025.109913_bib14","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.surg.2025.109913_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s11605-021-05211-x","article-title":"Evaluation of four lymph node classifications for the prediction of survival in hilar cholangiocarcinoma","volume":"26","author":"Liu","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109913_bib16","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1245\/s10434-024-16492-2","article-title":"Advantage of log odds of metastatic lymph nodes after curative-intent resection of gallbladder cancer","volume":"32","author":"Catalano","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jamcollsurg.2016.02.012","article-title":"Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme","volume":"222","author":"Bagante","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2025.109913_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.649699","article-title":"A novel nomogram based on log odds of metastatic lymph nodes to predict overall survival in patients with perihilar cholangiocarcinoma after surgery","volume":"11","author":"Zou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hpb.2024.11.007","article-title":"Lymphadenectomy for perihilar cholangiocarcinoma: therapeutic benefit of lymph node number and station","volume":"27","author":"Kawashima","year":"2024","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109913_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis","volume":"18","author":"van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.surg.2025.109913_bib22","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1097\/SLA.0000000000004150","article-title":"The relationship between lymph node ratio and survival benefit with adjuvant chemotherapy in node-positive esophageal adenocarcinoma","volume":"275","author":"Raman","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib23","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.3748\/wjg.v26.i25.3542","article-title":"Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma","volume":"26","author":"Dondossola","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2025.109913_bib24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1245\/s10434-024-16817-1","article-title":"Correction: a multicenter retrospective study on adjuvant S-1 chemotherapy versus observation following major hepatectomy for perihilar cholangiocarcinoma","volume":"32","author":"Hosokawa","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib25","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1245\/s10434-018-6388-7","article-title":"Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study","volume":"25","author":"Nassour","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejso.2021.12.002","article-title":"Adjuvant chemotherapy for perihilar cholangiocarcinoma: a population-based comparative cohort study","volume":"48","author":"Kamarajah","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib27","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","article-title":"Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma","volume":"40","author":"Kang","year":"2016","journal-title":"World J Surg"},{"issue":"4 Pt A","key":"10.1016\/j.surg.2025.109913_bib28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejso.2019.11.499","article-title":"Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: a systematic review and meta-analysis","volume":"46","author":"Rangarajan","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/SLA.0b013e3182822277","article-title":"Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes","volume":"257","author":"Aoba","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjsurg.2015.05.015","article-title":"Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review","volume":"210","author":"Kambakamba","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2025.109913_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SLA.0b013e3181d3d2b2","article-title":"Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma","volume":"251","author":"Ito","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gassur.2023.11.008","article-title":"Prognostic value of nodal staging classification and number of examined lymph nodes among patients with ampullary cancer","volume":"28","author":"Resende","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2025.109913_bib33","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-022-13044-4","article-title":"Predictors, patterns, and impact of adequate lymphadenectomy in intrahepatic cholangiocarcinoma","volume":"30","author":"Moazzam","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib34","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1245\/s10434-016-5243-y","article-title":"Prognostic implications of lymph node status for patients with gallbladder cancer: a multi-institutional study","volume":"23","author":"Amini","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","article-title":"Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers","volume":"274","author":"Mueller","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bjs\/znad057","article-title":"Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?","volume":"110","author":"van Keulen","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2025.109913_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","article-title":"Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer","volume":"260","author":"Merkow","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109913_bib38","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1245\/s10434-014-3722-6","article-title":"The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma","volume":"21","author":"Wu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109913_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4143\/crt.2023.784","article-title":"Impact of patient sex on adverse events and unscheduled utilization of medical services in cancer patients undergoing adjuvant chemotherapy: a multicenter retrospective cohort study","volume":"56","author":"Choi","year":"2024","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.surg.2025.109913_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2018.02.011","article-title":"Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy","volume":"119","author":"Borghaei","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.surg.2025.109913_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.annonc.2020.10.477","article-title":"Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial","volume":"32","author":"Petrelli","year":"2021","journal-title":"Ann Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025007652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025007652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:19:35Z","timestamp":1781511575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606025007652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0039606025007652"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109913","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109913"}}